These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27367207)

  • 1. Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein-Barr virus-positive patients with chronic lymphocytic leukemia.
    Diamantopoulos PT; Sofotasiou M; Georgoussi Z; Giannakopoulou N; Papadopoulou V; Galanopoulos A; Kontandreopoulou E; Zervakis P; Pallaki P; Kalala F; Kyrtsonis MC; Dimitrakopoulou A; Vassilakopoulos T; Angelopoulou M; Spanakis N; Viniou NA
    Cancer Med; 2016 Sep; 5(9):2240-8. PubMed ID: 27367207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin messenger RNA levels in Epstein-Barr virus-positive patients with leukemic low-grade B-cell lymphomas expressing the latent membrane protein 1: evidence of apoptotic function?
    Diamantopoulos PT; Polonyfi K; Sofotasiou M; Mantzourani M; Galanopoulos A; Spanakis N; Papadopoulou V; Kalala F; Iliakis T; Zareifi DS; Kodandreopoulou E; Vassilakopoulos T; Angelopoulou M; Siakantaris M; Terpos E; Variami E; Kollia P; Vaiopoulos G; Pangalis G; Viniou NA
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):56-60. PubMed ID: 24262330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival.
    Ferrajoli A; Ivan C; Ciccone M; Shimizu M; Kita Y; Ohtsuka M; D'Abundo L; Qiang J; Lerner S; Nouraee N; Rabe KG; Rassenti LZ; Van Roosbroeck K; Manning JT; Yuan Y; Zhang X; Shanafelt TD; Wierda WG; Sabbioni S; Tarrand JJ; Estrov Z; Radovich M; Liang H; Negrini M; Kipps TJ; Kay NE; Keating M; Calin GA
    EBioMedicine; 2015 Jun; 2(6):572-82. PubMed ID: 26288818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival.
    Visco C; Falisi E; Young KH; Pascarella M; Perbellini O; Carli G; Novella E; Rossi D; Giaretta I; Cavallini C; Scupoli MT; De Rossi A; D'Amore ES; Rassu M; Gaidano G; Pizzolo G; Ambrosetti A; Rodeghiero F
    Oncotarget; 2015 Jul; 6(21):18653-63. PubMed ID: 26087198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus latent membrane protein 1 mRNA is expressed in a significant proportion of patients with chronic lymphocytic leukemia.
    Tarrand JJ; Keating MJ; Tsimberidou AM; O'Brien S; LaSala RP; Han XY; Bueso-Ramos CE
    Cancer; 2010 Feb; 116(4):880-7. PubMed ID: 20052729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
    Price AM; Messinger JE; Luftig MA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for regulation of oxidative stress by latent membrane protein 1 oncoprotein in patients with low-grade leukemic B cell lymphoma with latent Epstein-Barr virus infection.
    Papadopoulou V; Diamantopoulos PT; Kontandreopoulou E; Polonyfi K; Variami E; Kouzis P; Galanopoulos A; Spanakis N; Zervakis K; Iliakis T; Perrea D; Kollia P; Vassilakopoulos TP; Pangalis GA; Kyrtsonis C; Vaiopoulos G; Viniou NA
    Leuk Lymphoma; 2014 Aug; 55(8):1904-9. PubMed ID: 24261679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus positive peripheral T cell lymphoma with novel variants in STAT5B of a pediatric patient: a case report.
    Chen Z; Gao L; Wang M; Tang Y; Zhao S; Liu W
    BMC Cancer; 2018 Apr; 18(1):373. PubMed ID: 29615001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.
    Ma SD; Xu X; Plowshay J; Ranheim EA; Burlingham WJ; Jensen JL; Asimakopoulos F; Tang W; Gulley ML; Cesarman E; Gumperz JE; Kenney SC
    J Clin Invest; 2015 Jan; 125(1):304-15. PubMed ID: 25485679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus.
    Chen H; Hutt-Fletcher L; Cao L; Hayward SD
    J Virol; 2003 Apr; 77(7):4139-48. PubMed ID: 12634372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Epstein-Barr virus in pediatric leukemia in the Sudan.
    Ahmed HG; Osman SI; Ashankyty IM
    Clin Lymphoma Myeloma Leuk; 2012 Apr; 12(2):127-31. PubMed ID: 22264774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
    Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G
    J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL.
    Kanemitsu N; Isobe Y; Masuda A; Momose S; Higashi M; Tamaru J; Sugimoto K; Komatsu N
    Clin Cancer Res; 2012 Apr; 18(8):2164-72. PubMed ID: 22371452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus gene expression and latent membrane protein 1 gene polymorphism in pediatric liver transplant recipients.
    Kasztelewicz B; Jankowska I; Pawłowska J; Teisseyre J; Dzierżanowska-Fangrat K
    J Med Virol; 2011 Dec; 83(12):2182-90. PubMed ID: 22012727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection.
    Yoshioka M; Ishiguro N; Ishiko H; Ma X; Kikuta H; Kobayashi K
    J Gen Virol; 2001 Oct; 82(Pt 10):2385-2392. PubMed ID: 11562532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.
    Xiao W; Chen WW; Sorbara L; Davies-Hill T; Pittaluga S; Raffeld M; Jaffe ES
    Hum Pathol; 2016 Sep; 55():108-116. PubMed ID: 27184478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].
    Yakovleva LS; Senyuta NB; Goncharova EV; Scherback LN; Smirnova RV; Pavlish OA; Gurtsevitch VE
    Mol Biol (Mosk); 2015; 49(5):800-10. PubMed ID: 26510598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of latent membrane protein 1 expression on overall survival in Epstein-Barr virus-associated cancers: a literature-based meta-analysis.
    Chen YP; Zhang WN; Chen L; Tang LL; Mao YP; Li WF; Liu X; Zhou GQ; Sun Y; Kang TB; Zeng MS; Liu N; Ma J
    Oncotarget; 2015 Oct; 6(30):29311-23. PubMed ID: 26336130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines and Epstein Barr virus (EBV) genes expression in blood chronic lymphocytic leukaemia (CLL) cells and their immortalised CLL cell lines.
    Laytragoon-Lewin N; Chen F; Castro J; Avila-Carino J; Lewin F
    Anticancer Res; 2003; 23(5A):4017-22. PubMed ID: 14666712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.